Physician profile
Bailey Young
NPI 1356701502
$1,405.76
in general payments reported to CMS, 2019-2025
17 companies · $302 in 2025
The $302 reported for 2025 was more than what 89% of Pediatric Emergency Medicine (Pediatrics) providers received nationally (typical 2025 total: $53.43).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $184 · 2020: $20.92 · 2021: $172 · 2022: $112 · 2023: $35.75 · 2024: $578 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $817 · Education: $99.23.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $817.02 |
| Education | $99.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $489.51 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $261.70 | 2024 | Fasenra, Tezspire |
| Regeneron Healthcare Solutions, INC. | $99.23 | 2024 | Dupixent |
| Baxter Healthcare | $93.60 | 2024-2025 | Hillrom - Vest System Model 105 Home Care |
| Jazz Pharmaceuticals INC. | $81.50 | 2024-2025 | |
| Vertex Pharmaceuticals Incorporated | $71.56 | 2024-2025 | |
| Philips North America LLC | $63.10 | 2025 | Vest Therapy Und |
| Genzyme Corporation | $50.99 | 2023-2024 | |
| Avadel Cns Pharmaceuticals, LLC | $30.37 | 2025 | Lumryz |
| Abbvie INC. | $30.16 | 2024-2025 | |
| Viatris Specialty LLC | $27.15 | 2025 | Tobi Podhaler |
| Phadia US INC. | $22.85 | 2024 | Immunocap |
| Tactile Systems Technology INC | $19.44 | 2025 | Flexitouch Plus, Nimbl |
| Amgen INC. | $18.67 | 2024 | Tezspire |
| Mylan Specialty L.P. | $17.98 | 2024 | Tobi Podhaler |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Azurity Pharmaceuticals, INC. | $14.79 | 2025 | Alvesco |
| Aimmune Therapeutics, INC. | $13.16 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bailey Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.